0
A breathalyzer that reverse-transcribes RNA from airborne SARS-CoV-2 in breath predicts lower respiratory tract involvement and is less invasive than alternative testing approaches, report researchers.
A breathalyzer that reverse-transcribes RNA from airborne SARS-CoV-2 in breath predicts lower respiratory tract involvement and is less invasive than alternative testing approaches, report researchers.